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Abstract
Background
Akkermansia muciniphila and Desulfovibrio spp. are commensal microbes colonising the
mucus gel layer of the colon. Both species have the capacity to utilise colonic mucin as a
substrate. A.muciniphila degrades colonic mucin, while Desulfovibrio spp. metabolise the
sulfate moiety of sulfated mucins. Altered abundances of these microorganisms have been
reported in ulcerative colitis (UC). However their capacity to bind to human colonic mucin,
and whether this binding capacity is affected by changes in mucin associated with UC,
remain to be defined.
Methods
Mucin was isolated from resected colon from control patients undergoing resection for
colonic cancer (n = 7) and patients undergoing resection for UC (n = 5). Isolated mucin was
purified and printed onto mucin microarrays. Binding of reference strains and three clinical
isolates of A.muciniphila and Desulfovibrio spp. to purified mucin was investigated.
Results
Both A.muciniphila and Desulfovibro spp. bound to mucin. The reference strain and all clini-
cal isolates of A.muciniphila showed increased binding capacity for UC mucin (p < .005).
The Desulfovibrio reference strain showed increased affinity for UC mucin. The mucin
binding profiles of clinical isolates of Desulfovibrio spp. were specific to each isolate. Two
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isolates showed no difference in binding. One UC isolate bound with increased affinity to
UC mucin (p < .005).
Conclusion
These preliminary data suggest that differences exist in the mucin binding capacity of iso-
lates of A.muciniphila and Desulfovibrio spp. This study highlights the mucin microarray
platform as a means of studying the ability of bacteria to interact with colonic mucin in health
and disease.
Introduction
The mucus gel layer (MGL) forms a protective barrier between colonic epithelium and colonic
contents, preventing entry of bacteria while allowing diffusion of essential nutrients [1].
Mucins constitute the functional units of the MGL, with MUC2 representing the principal
component of colonic mucus [2, 3]. Due to a high degree of glycosylation, mucins provide an
energy source and a growth medium for mucus-associated microbiota [2], that in health exist
in a symbiotic relationship with the host [4]. Due to their close proximity to the epithelium,
microbes present within the MGL of the colon exert a greater effect on the host than luminal
microbes [5]. The intestinal microbiota modulates a variety of host responses, including those
related to metabolism which the host has not developed for itself [4, 6, 7]. Through foraging of
carbohydrates from both dietary sources and colonic mucins, the microbiota provides an
energy source through the production of short chain fatty acids (SCFAs) [7]. Interaction
between the microbiota and colonic mucins warrants investigation, as this represents the true
host microbial interface in the colon.
In ulcerative colitis (UC), changes occur in the MGL that may alter its protective capacity
[8–10]. These include physical changes in the mucus barrier [11], altered mucin gene expres-
sion [12] and biochemical changes affecting the mucins [13]. Increased microbial colonisation
of the MGL has been reported in UC [14]. Changes in colonic mucus and mucin may influence
bacterial colonisation in the inflamed colon, due to altered availability of mucin-derived sub-
strate, leading to an altered microenvironment. In addition there is substantial evidence of a
dysbiosis in UC [15–17]. As a result, changes in relative abundances of certain bacterial taxa in
the UC setting may affect mucin production and secretion [18].
This study focuses on two colonic commensals A.muciniphila and Desulfovibrio spp., both
of which have the potential to metabolise colonic mucin. A.muciniphila is known to have
mucolytic potential in-vitro [19] and may have a role in stimulation of the immune system and
maintenance of tolerance to commensal microbes [20, 21]. A.muciniphilamay also be involved
in a “positive feedback loop” whereby mucolytic properties may stimulate mucus renewal [22].
Furthermore, this microbe binds to colonic cell lines and may contribute to maintenance of the
integrity of the colonic epithelial cell layer [23]. In UC, the abundance of A.muciniphila is
reduced [24, 25]. However, it remains to be determined whether this change is related to
altered binding to colonic mucin.
Desulfovibrio spp. may contribute to mucosal inflammation in UC through production of
potentially toxic hydrogen sulfide, released as a by-product of metabolism of sulfated mucin
[26–31]. It is not known whether Desulfovibrio spp. is capable of directly binding mucin or
whether it metabolises sulfate from mucin that has been cleaved by other bacteria.
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The present study utilises a mucin microarray platform as a means of testing the hypothesis
that mucolytic microbes bind to human colonic mucin and investigates the affinity for mucin
in health and UC.
Materials and Methods
Ethical approval, patient recruitment and sample collection
Ethical approval was obtained from St. Vincent’s University Hospital Ethics and Medical
Research Committee. All individuals gave informed, written consent prior to the procedure.
For the collection of mucin specimens, seven control patients undergoing colonic resection
for cancer and five patients with UC undergoing colectomy were recruited. For the control
mucin, paired biopsies of approximately 2 cm2 of mucosal tissue were resected from the excised
colon at least 5 cm from the tumour. Similar paired biopsies of mucosa from patients with UC
were obtained from the caecum, transverse, left colon and rectum of fresh surgical resection
specimens. Patients had not received bowel preparation prior to undergoing surgery. In each
case, one of the paired samples for mucin isolation was freshly frozen and one for histological
analysis was stored in formalin.
Mucus was harvested and mucin purified as previously described [32, 33]. In brief, mucus
was suspended in guanidine hydrochloride (final concentration 4M) to form a solution. Sam-
ples were reduced with dithiothreitol (DTT) (Sigma Aldrich) at a final concentration of 0.01M
at 37°C for 5 hours and were alkylated with iodoacetamide (0.025M) (Sigma Aldrich). Mucin
was purified by CsCl density gradient separation and size exclusion chromatography.
For bacterial isolation, mucosal biopsies were obtained from one control patient, and three
patients with active UC. The healthy volunteer was asymptomatic and undergoing a screening
colonoscopy for family history of colorectal carcinoma. This patient had no mucosal evidence
of pathology. Bowel preparation was sodium picosulfate based. Exclusion criteria included:
antibiotic usage or hospital admission in the six weeks prior to colonoscopy, a history of bleed-
ing per rectum, personal history of irritable bowel syndrome or colorectal carcinoma. The
biopsy was obtained using a RadialJaw 3 biopsy forceps (Boston Scientific, Natick, MA, USA)
and was retrieved with a sterile needle to prevent external contamination. Biopsies from
patients with UC were obtained from rectal mucosa at the time of surgical resection for disease
refractory to medical management. Approximately 1 cm2 of mucosa was resected using sterile
instruments.
Bacterial strains, bacterial isolations and culture
The A.muciniphila reference strain ATCCBAA-835 (American Type Culture Collection,
Manassas, VA) and Desulfovibrio desulfuricans reference strain ATCC 27774 (American Type
Culture Collection) were cultured according to the suppliers guidelines using BHI (Sigma
Aldrich, Dublin, Ireland) and a modified Postgate’s medium respectively. Modified Postgate’s
medium was prepared as follows: K2PO4 0.5g/L, NH4CL 0.5 g/L, CaSO4 1 g/L, MgSO4.7H2O 2
g/L, sodium lactate 3.5 g/L, yeast extract 1 g/L, 30 g/L fastidious anaerobic broth (Lab M Ltd.,
Bury, Manchester, UK), and ascorbic acid 0.1 g/L and autoclaving at 121°C for 15 min. Filter
sterilised FeSO4 was added to the modified Postgate’s medium at a concentration of 0.5 g/L
immediately prior to use. All reagents were sourced from Sigma Aldrich unless otherwise
stated. Cultures were placed in a shaking incubator at 200 rpm at 37°C for 16 hours under
anaerobic conditions achieved by the use of AnaeroGen anaerobic gas packs (Oxoid, Basing-
stoke, UK).
Fresh colonic mucosal samples were placed directly into 5 ml of sterile phosphate buffered
saline (PBS) immediately after resection and stored at 4°C until culturing. Immediately prior to
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culturing, samples were vortexed for 30 seconds and 1 ml of the PBS solution was inoculated
into 50 ml of Brain Heart Infusion(BHI) broth and 50 ml of modified Postgate’s medium broth
for isolation of A.muciniphila and Desulfovibrio spp. respectively. Cultures of A.muciniphila
were incubated for 16 hours and Desulfovibrio spp. for up to 72 hours. Following growth, as
evidenced by a cloudy appearance of BHI broth and a black precipitate accompanied by the
odour of hydrogen sulfide in the case of modified Postgate’s medium, the cultures were sub-
cultured onto BHI and a modified Postgate’s medium agar. The modified Postgate’s medium
agar was prepared as described above plus the addition of 15 g/L of bacteriologic agar. Cultures
were incubated at 37°C overnight under anaerobic conditions achieved by the use of Anaero-
Gen anaerobic gas packs (Oxoid). Sub-culturing was repeated until a pure growth of each iso-
late was obtained.
Growth of A.muciniphila was characterised by white colonies measuring approximately 0.7
mm in diameter as previously described [19]. Gram staining was performed to confirm the
presence of gram negative oval-shaped cells characteristic of A.muciniphila. Colonies of Desul-
fovibrio spp. were identified as described above. Isolates of A.muciniphila and Desulfovibrio
spp. were stored at -80°C on cryopreservative beads (MicroBank, ProLab Diagnostics, ON,
Canada) until further analysis.
To confirm the identity of clinical isolates, PCR using an assay specific for each bacterial tar-
get was performed. DNA extraction was performed on a single colony from each culture by re-
suspending in PBS followed by four heat/freeze cycles at 100°C and -80°C. Conventional PCR
targeting the 16S rRNA gene of each target was performed using oligonucleotide primers tar-
geting A.muciniphila (forward primer 5’- CAGCACGTGAAGGTGGGGAC– 3’ reverse primer
5’- CCTTGCGGTTGGCTTCAGAT-3’) [24] and Desulfovibrio spp. (forward primer 5’-
CCGTAGATATCTGGAGGAACATCAG -3’, reverse primer 5’-ACARCTAGCATCCATCGTT
TACAGC-3’) [34] respectively. All PCR reactions contained 1X My Taq Red Mix (Bioline,
London, UK), forward primer and reverse primer at a final concentration of 200 nM. For
Desulfovibrio spp., each reaction contained 5 μl of DNA template and for A.muciniphila reac-
tions contained 10 μl of DNA template. Each assay run incorporated a negative control and a
reference sample of cloned 16S rRNA gene from Desulfovibrio spp. or A.muciniphila as a posi-
tive control. All reactions were carried out on a Multigene thermocycler (Labnet International
Inc., Woolbridge, NJ, U.S.A.) under the following cycling conditions: A.muciniphila 95°C for
10 seconds initially, followed by 30 cycles of 95°C for one minute, 50°C for one minute, 68°C
for 10 seconds. PCR conditions for Desulfovibrio spp. were: 95°C for 5 minutes initially, fol-
lowed by 35 cycles of 95°C for 1 minute, 62°C for 1 minute, 72°C for 45 seconds and a final
extension step at 72°C for 5 minutes. PCR products were analysed by electrophoresis in a 2%
agarose gel stained with 0.5 μg/ml ethidium bromide (Sigma) and visualised under ultra violet
light immediately after electrophoresis. Products of A.muciniphila and Desulfovibrio spp. were
visualised at 327 and 135 base pairs, respectively.
Histological analysis of specimens from which mucin was isolated
Formalin fixed, paraffin embedded mucosal biopsy specimens for each mucin sample were
stained using Haematoxylin and eosin stain (H&E) and High Iron Diamine-Alcian Blue
(HID-AB) staining to quantify degree of inflammation and percentage sulfation as previously
described [35]. For each specimen, the quantity of sulfated mucin was determined and results
expressed as the percentage relative to the total mucin content for a given specimen. For histo-
logical analysis, UC specimens were scored as mild, moderate or severe inflammation, accord-
ing to the system described by Geboes et al [36]. Control specimens were described as normal
mucosa.
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Interrogation of mucin array for bacterial binding
Printing of the purified human colonic mucins on Nexterion slide H microarray slides was
optimised and printed as previously described (S1 Table) [32]. Each microarray slide was
printed with eight replicate subarrays, with each mucin printed in six replicates (per subarray).
Microarray slides were blocked and washed as previously described [32]. Print performance
and mucin glycosylation was assessed by incubating the microarray with a panel of tetra-
methylrhodamine-(TRITC-) labelled lectins, (see S2 Table for lectins and their incubation con-
centration) diluted in low salt Tris buffered saline supplemented with Ca2+ and Mg2+ ions
(TBS; 20 mM Tris-HCl, 100 mMNaCl, 1 mM CaCl2, 1 mMMgCl2, pH 7.2) with 0.05%
Tween-20 (TBS-T) as previously described [32].
Prior to incubation on the microarrays,Desulfovibrio spp. were cultured overnight in iron-
free modified Postgate’s medium. Bacterial strains of A.muciniphila and Desulfovibrio spp. were
re-suspended to an optical density 600 nm (OD600) of 0.1. Bacteria were cultured for 2.5 hours as
described above and harvested by centrifugation of 1 ml of each culture at 16,200 x g for 1 min,
the supernatant discarded and the pellet re-suspended to an OD600 of 1.0 in TBS. Bacterial cul-
tures were labelled with SYTO82 nucleic acid fluorescent dye (Life Technologies, Carlsbad, CA,
U.S.A.) at a final concentration of 20 μM, protected from light and incubated for 45 min at room
temperature. Bacteria were washed seven times with 1 ml of TBS for each wash to completely
remove unbound dye [37]. The final pellet was re-suspended to an OD600 of 0.5 with TBS-T.
The mucin microarray slides were initially rehydrated by incubating 70 μl of TBS per subar-
ray using an Agilent eight-well gasket slide and incubation cassette system (Agilent Technolo-
gies, Cork, Ireland) at 37°C for 45 min. The TBS was removed and the microarray slides were
subsequently incubated with 70 μl of fluorescently labelled bacteria at an OD600 of O.5 per sub-
array. Two subarrays on each microarray slide were incubated with TRITC-labelled lectins
Artocarpus integrifolia (AIA, 15 ug/mL TBS-T, final concentration) andMaackia amurensis
agglutinin (MAA, 10 ug/mL TBS-T, final concentration) (EY Laboratories Ltd., San Mateo,
CA, USA) to monitor print performance. The slides were incubated in a shaking incubator at
200 rpm at 37°C for 1hr followed by washing five times in TBS-T, once in TBS and once in
water. Slides were dried by centrifugation at 266 x g for 5 min and scanned immediately in a
GenePix 4000b microarray scanner (Molecular Devices, Wokingham, UK) with the 532 nm
laser using the following settings; laser power 100%, 10μm resolution and 70% PMT [33]. Anal-
ysis of each bacterial isolate consisted of two technical replicates per microarray slide and three
biological replicates on different microarray slides, resulting in a total of six data sets for each
isolate. These methods are summarised in Fig 1.
Data extraction and analysis
Data were extracted from the scanned images using GenePix pro software (Molecular Devices)
and then exported to Excel for subsequent analysis and normalisation as previously described
[33, 37]. The median of six replicate features per subarray was handled as a single data point
for graphical and statistical analysis. Data intensities across the three replicate microarray slides
were normalised against the ratio of total subarray fluorescence/mean total fluorescence of the
six replicate subarrays to account for inter-microarray slide variability and minimise the effect
of variation in mucin printing. Mucin micro-array data are available in the supplementay
information (S3 and S4 Tables)
Glycosylation Profiles of Human Colonic Mucins
Data generated from lectin profiling of the mucin microarray were used to compare the glyco-
sylation profiles of human colonic mucins in health and UC (Fig 2). Sialylation, as indicated by
Akkermansia muciniphila and Desulfovibrio spp. Bind to Colonic Mucin
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MAA binding, is present in the colonic mucins. Sulfation, as determined by WFA binding with
low or without concomitant SBA binding, was most present in the control mucins. Varying
quantities of sialylated or sulfated O-linked oligosaccharides were present throughout the sam-
ples as determined by varying intensities of AIA binding.
Fig 1. Summary of Materials andMethods.
doi:10.1371/journal.pone.0135280.g001
Fig 2. Comparison of the glycosylation profiles of human colonic mucins generated from lectin
profiling of the mucin microarray. The maximum binding for colonic mucins is 8,335 RFU. The highest
intensity binding is represented by red, followed by orange, yellow and white.
doi:10.1371/journal.pone.0135280.g002
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Statistical analysis
Normalised data were exported to SPSS statistics, version 20.0 (SPSS statistics, IBM, London,
U.K.) for statistical analysis. Statistical comparisons were performed based on Mann-Whitney
U test and Kruskal-Wallis comparisons.
Results
HID-AB analysis of biopsies collected from each individual indicated that UC mucin had a
median percentage sulfomucin of 39.51% (IQR 32.68%) and controls a median of 57.69% (IQR
16.74%). On histological analysis of mucosal biopsies obtained from patients with UC, four
were classified as severely inflamed and one as moderately inflamed according to the Geboes
scoring system [36]. Control biopsies were described as normal mucosa.
Three isolates of both A.muciniphila and Desulfovibrio spp. were successfully cultured from
different individuals. One isolate of A.muciniphila and Desulfovibrio spp. was isolated from a
control patient, and two isolates of both species were isolated from three individuals with UC.
A.muciniphila and Desulfovibrio spp. bound to colonic mucin in health
and UC
Both A.muciniphila and Desulfovibro bound to colonic mucin (Table 1). Clinical isolates of A.
muciniphila did not differ from the reference strain with regard to binding to control and UC
mucin (Fig 3a and 3b, Table 1). However, all clinical isolates of Desulfovibrio spp. showed dif-
ferences in comparison to the reference strain D. desulfuricans. One isolate of Desulfovibrio
spp., cultured from a patient with UC, (UC isolate B) displayed increased binding to mucin
from controls compared to the reference strain (Fig 3c, Table 1), while the healthy isolate and
one UC isolate (UC isolate A) of Desulfovibrio spp. bound to mucin isolated from UC colon
with reduced affinity compared to the reference strain (Fig 3d, Table 1).
Isolates of A.muciniphila and Desulfovibrio spp. display increased
binding to mucin from the UC colon
In a direct comparison of bacterial binding to mucin from UC and controls, both the reference
strain and all three clinical isolates of A.muciniphila displayed increased affinity for UC mucin
compared to mucin from controls (Fig 4a, Table 2).
In the case of Desulfovibrio spp., the reference strain and one isolate from a patient with UC
(UC isolate B) bound with increased affinity to UC mucin compared to mucin from controls,
while the healthy isolate and the isolate from the second patient with UC (UC isolate A)
showed no difference in binding (Fig 4b, Table 2).
Discussion
UC is associated with changes in colonic mucins thought to be related to dysregulated cross-
talk between the host and an altered microbiota. Mucin binding is the first point of bacterial
interaction with the host and, as such, is a key mediator of this cross-talk. The present study
investigated the ability of two commensals that have been implicated in the pathogenesis of
UC, to bind to colonic mucin.
These preliminary data demonstrate for the first time that both A.muciniphila and Desulfo-
vibrio spp. have the ability to bind to human colonic mucin. However, no adhesins have been
identified in the currently annotated genome of either A.muciniphila or Desulfovibrio spp.
[38]. Previous studies have demonstrated the ability of A.muciniphila to degrade both porcine
mucin and human mucin in-vitro [19, 24] and provided putative evidence that A.muciniphila
Akkermansia muciniphila and Desulfovibrio spp. Bind to Colonic Mucin
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Table 1. Median binding values of each isolate to mucin from controls and the UC colon and Kruskal-Wallis tests comparing the binding of clinical
isolates to that of the reference strain for A.muciniphila andDesulfovibrio spp.
A. muciniphila Median
binding to
Control
mucin(FU)
IQR Kruskal-Wallis
and Wilcoxin-
Mann-Whitney
Fold change in
binding compared
to the reference
strain
Median
binding to
UC mucin
(FU)
IQR Kruskal-Wallis
and Wilcoxin-
Mann-Whitney
Fold change in
binding compared
to the reference
strain
.077 .148
Reference 559.83 970.89 n/a 2022.41 2076.05 n/a
Healthy isolate 362.58 493.62 n/a -0.65 1221.52 2176.76 n/a -0.60
UC isolate A 636.67 593.58 n/a +1.14 3075.48 2398.98 n/a +1.52
UC isolate B 792.37 908.92 n/a +1.42 3251.41 2165.19 n/a +1.61
Desulfovibrio
spp.
<0.005 <0.005
Reference 95.10 107.73 n/a 368.34 501.99 n/a
Healthy isolate 70.44 79.30 1.00 -0.74 39.60 155.02 <0.005 -0.11
UC isolate A 73.94 113.35 1.00 -0.78 119.74 238.59 .014 -0.32
UC isolate B 145.38 283.64 .022 +1.53 712.41 930.06 .276 +1.93
Significant values are highlighted in bold text. FU corresponds to measure of bacterial binding in fluorescent units. IQR corresponds to inter quartile range.
doi:10.1371/journal.pone.0135280.t001
Fig 3. Boxplots illustrating the binding of clinical isolates and reference strains to mucin from different sources.Median binding of isolates of A.
muciniphila to control mucin (a) Median binding of isolates of A.muciniphila to UCmucin (b) Median binding of isolates of Desulfovibrio spp. to control mucin
(c) Median binding of isolates of Desulfovibrio spp. to UCmucin (d).
doi:10.1371/journal.pone.0135280.g003
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express BACON (Bacteriodetes-associated carbohydrate-binding Often N-terminal), a protein
believed to mediate mucin binding [38, 39]. The present results indicate the likely production
of such mucin binding proteins, or the presence of carbohydrate binding motifs (CBMs), a
family of domains that bind various polysaccharides, enhancing their degradation and may
interact with mucin glycan structures [40–43]. Alternatively, non-specific interactions based
on hydrophobicity have been described as an adhesion mechanism in the colon [44, 45].
The observed differences in binding may be explained by strain-specific differences in the
binding capacity of the microbes or alterations to mucin in UC that promote increased mucin
binding. The present study focused on a number of clinical isolates and their commercially
available ATCC reference strain counterparts. While the identity of all isolates was confirmed
by PCR, no information regarding the strain specificities was obtained. It is known that differ-
ent strains of a bacterial species may possess different adhesion molecules [46–48] and that
selective pressures and natural mutations have the potential to alter these adhesion molecules
[49–51]. Given these observations and the selective pressure placed upon bacteria to survive in
Fig 4. Boxplots representing the median binding of each isolate and reference strain to mucin from
the UC colon compared to controls.Direct comparison of the median binding of isolates of A.mucinihpila
(a). Direct comparison of median binding of isolates of Desulfovibrio spp. (b).
doi:10.1371/journal.pone.0135280.g004
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a niche environment like the colonic MGL, it is possible that strain specific differences in adhe-
sion molecules explain the observed difference in mucin binding.
Mucin in the UC colon shows reduced sulfation [35, 52, 53], possibly the result of bacterial
sulphatase activity [54, 55], as well as changes in the degree of mucin glycosylation [13]. The
data presented here indicate a reduction in the median percentage sulphation in UC mucin
compared to control mucin. Longman et al. did not report significant differences in the histo-
chemistry of UC samples compared to healthy colorectal tissue using the same staining tech-
nique. However the study did not quantify sulfomucin content and did report reduced staining
of the sulfo-Lewis mucin epitope, a finding that correlated with disease severity [10]. Alter-
ations in mucin glycosylation patterns were also observed in the present study, as outlined in
Fig 2. The resultant change in the microenvironment of the MGL may well influence the bind-
ing capacity of the resident microbiota. In health, the presence of the sulphate moiety is
thought to protect mucin against degradation by colonic microbes [52]. The loss of sulphation,
whether enzymatically mediated or through biosynthetic reduction, could alter the mucin sub-
strate for bacterial binding. This may occur though the loss of a sugar binding ligand, in which
case a reduction in binding would be observed. Alternatively, presentation of a new or previ-
ously cryptic ligand after desulfation, possibly mediated by enhanced susceptibility to mucinase
activity [56], may result in increased bacterial binding. Exposure of such motifs could explain
the increased binding of A.muciniphila and Desulfovibrio spp. to UC mucin.
It has previously been reported that A.muciniphila has the ability to bind to adenocarci-
noma-derived cell lines Caco2 and HT-29, but not to colonic mucus [23]. Healthy colonocytes
produce a mucus layer that is rich in O-acetylated sialic acids [57]. The oligo-O-acetylation of
sialic acids is lost in colorectal cancer and may be an early biomarker in the adenoma-carci-
noma sequence [58, 59]., a finding that may account for the high binding of A.muciniphila to
adenocarcinoma-derived cell lines. Although the degree of O-acetylation of sialic acids was not
evaluated in the present study, it warrants consideration as a possible important modulator of
bacterial binding.
It should also be considered that the binding process itself may influence subsequent bind-
ing events. Mucin-microbe interactions have previously been investigated by Skoog et al., who
demonstrated that weak interactions between Helicobacter pylori and gastric mucin result in
increased expression of H. pylori adhesion factors in an in-vitromodel [60]. It is possible that
Table 2. Comparison of bacterial binding to control and UCmucin as determined by the Mann-Whitney U test.
Bacterial Target Isolate Median Binding to mucin from
controls (FU)
IQR Median Binding to UC
mucin (FU)
IQR Mann- Whitney U(p
value)
A. muciniphila Reference 559.83 970.89 2022.41 2076.05 .001
Healthy
isolate
362.58 493.62 1221.52 2176.76 .000
UC isolate A 636.67 593.58 3075.48 2398.98 .000
UC isolate B 792.37 908.92 3251.41 2165.19 .000
Desulfovibrio
spp.
Reference 95.10 107.73 368.34 501.99 .000
Healthy
isolate
70.44 79.30 39.59 155.02 .803
UC isolate A 73.94 113.35 119.74 238.59 .456
UC isolate B 145.38 283.64 712.41 930.06 .000
Significant values are highlighted in bold text. FU corresponds to measure of bacterial binding in fluorescent units. IQR corresponds to inter quartile range.
doi:10.1371/journal.pone.0135280.t002
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similar events may be occurring in the case of these commensals and other commensals or
pathogens within the colon.
While the present study has identified differences in the affinity of A.muciniphila and
Desulfovibrio spp. for mucin from the inflamed and non-inflamed colon, it should be acknowl-
edged that the purified mucin used in this study lacks many of the physiological factors and
constituents of mucus such as inflammatory mediators and cytokines, that in-vivomodulate
the physiology of colonic mucus and in turn may influence microbial binding. The authors
also acknowledge the low number of clinical isolates investigated in this study. While the
results have indicated that strain specific differences in the binding patterns of isolates of Desul-
fovibrio spp. exist, we are hesitant to suggest that these findings reflect how healthy and UC iso-
lates behave in all cases. Further study involving isolates from a larger number of individuals
(both healthy and UC) is required to more fully understand the mediators of mucin binding
in-vivo.
However, this work does highlight the potential for use of mucin microarray technology in
the investigation of microbe-mucin binding. Manipulation of the microbiota holds great
potential as a treatment modality in colorectal diseases. For such biotherapies to reach full
potential, a thorough understanding of the nature of the interactions between individual bacte-
rial species and the host is required. Assays such as those described in this study, advance
knowledge of microbe-mucin interactions in UC, as well as other gastrointestinal diseases.
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